News

Leap Program·Structural Improvement R&D·Innovation Premier 1000 consecutively selected… Establishing a ‘virtuous cycle of growth’ system of technology-production-export

Source = Provided by Reanzen Co., Ltd.

Reanzen Co., Ltd. (CEO Kwon Soon-ik), a bio-convergence specialized company that is attracting attention in the global anti-aging market with its high-functional filler and skin booster products, is in the process of fully implementing technology-centered global scale-up as it has been selected for key government innovation support projects one after another.

Recently, Reanzen has been selected for the Ministry of SMEs and Startups' 'Jump-Up Program', 'SME Technology Innovation Development Project (Structural Improvement R&D)', and the Financial Services Commission's 'Innovation Premier 1000'. The organically linked growth strategy from technology development (R&D) to production and export is attracting attention as it is aligned with the direction of the government program.

First, the 'Jump-Up Program' is a government policy that focuses on supporting promising small and medium-sized enterprises to enter new markets for three years, and Reanzen will receive comprehensive support including global network connections, policy vouchers, and dedicated directing. It is evaluated that this has laid a solid foundation for expanding into the global market.

In addition, Reanzen was selected for the 'Small and Medium Enterprise Technology Innovation Development Project (Structure Improvement R&D)' sector and secured about 500 million won in government subsidies. Through this project, Reanzen plans to fully pursue the development and commercialization of new products using biocompatible, highly functional materials. In particular, it is focusing on strengthening the competitiveness of high value-added products, for which global demand is rapidly increasing in the anti-aging field.

Here, it has established itself as a true technology leader by being included in the 'Innovation Premier 1000' project. This project is a national innovation growth strategy in which 12 ministries, including the Financial Services Commission and the Ministry of Trade, Industry and Energy, jointly select excellent companies by industry and provide customized financial and non-financial support until 2026. Reanzen was selected as a key fostering target company among small and medium-sized enterprises in recognition of its unique technological prowess and global expansion potential.

Kwon Soon-ik, CEO of Reanzen, said, “Achieving this triple crown is the result of public recognition of Reannzen’s technological prowess and market expansion potential,” and added, “Based on a virtuous cycle of growth that links technological development, product development, and exports, we will leap forward as a leading K-bio company leading the global anti-aging market.”

Meanwhile, Reanzen is continuing to grow in the domestic and international medical beauty markets, focusing on high-functional skin beauty products based on biocompatible biomaterials, and is also accelerating the expansion of exports to Singapore, the Middle East, Europe, and other regions.

출처 : 파이낸스투데이(http://www.fntoday.co.kr)